Role of Mapping and Ablation in Genetic Diseases: Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia

Steven J. Fowler, Larry A. Chinitz, Silvia G. Priori

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Management of patients with channelopathies represents a challenging field for the electrophysiologist because, given the absence of obvious structural abnormalities of the cardiac tissue, it is difficult to define paradigms for the use of mapping and ablation. Anecdotal reports and studies conducted in limited numbers of patients support the view that ablative procedures should be part of the clinical armamentarium used to treat ion channel disorders, yet conclusive data are far from being available. We believe that the nuanced nature of heritable arrhythmogenic disease presents distinct challenges to mapping and radiofrequency ablation; therefore, in the present chapter we review currently available studies as well as selected cases from our experience focusing on patients with long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This edition first published 2013

Original languageEnglish
Title of host publicationCardiac Mapping: Fourth Edition
PublisherWiley-Blackwell
Pages644-655
Number of pages12
ISBN (Print)9780470670460
DOIs
Publication statusPublished - Dec 18 2012

Fingerprint

Long QT Syndrome
Inborn Genetic Diseases
Channelopathies
Ion Channels
Polymorphic catecholergic ventricular tachycardia

Keywords

  • Ablation
  • Catecholaminergic
  • Disease
  • Genetic
  • Inherited
  • Long QT
  • Mapping
  • Ventricular arrhythmias

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Role of Mapping and Ablation in Genetic Diseases : Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia. / Fowler, Steven J.; Chinitz, Larry A.; Priori, Silvia G.

Cardiac Mapping: Fourth Edition. Wiley-Blackwell, 2012. p. 644-655.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fowler, Steven J. ; Chinitz, Larry A. ; Priori, Silvia G. / Role of Mapping and Ablation in Genetic Diseases : Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia. Cardiac Mapping: Fourth Edition. Wiley-Blackwell, 2012. pp. 644-655
@inbook{aba24d4a2d86436484125b5988739fc3,
title = "Role of Mapping and Ablation in Genetic Diseases: Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia",
abstract = "Management of patients with channelopathies represents a challenging field for the electrophysiologist because, given the absence of obvious structural abnormalities of the cardiac tissue, it is difficult to define paradigms for the use of mapping and ablation. Anecdotal reports and studies conducted in limited numbers of patients support the view that ablative procedures should be part of the clinical armamentarium used to treat ion channel disorders, yet conclusive data are far from being available. We believe that the nuanced nature of heritable arrhythmogenic disease presents distinct challenges to mapping and radiofrequency ablation; therefore, in the present chapter we review currently available studies as well as selected cases from our experience focusing on patients with long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This edition first published 2013",
keywords = "Ablation, Catecholaminergic, Disease, Genetic, Inherited, Long QT, Mapping, Ventricular arrhythmias",
author = "Fowler, {Steven J.} and Chinitz, {Larry A.} and Priori, {Silvia G.}",
year = "2012",
month = "12",
day = "18",
doi = "10.1002/9781118481585.ch59",
language = "English",
isbn = "9780470670460",
pages = "644--655",
booktitle = "Cardiac Mapping: Fourth Edition",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Role of Mapping and Ablation in Genetic Diseases

T2 - Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia

AU - Fowler, Steven J.

AU - Chinitz, Larry A.

AU - Priori, Silvia G.

PY - 2012/12/18

Y1 - 2012/12/18

N2 - Management of patients with channelopathies represents a challenging field for the electrophysiologist because, given the absence of obvious structural abnormalities of the cardiac tissue, it is difficult to define paradigms for the use of mapping and ablation. Anecdotal reports and studies conducted in limited numbers of patients support the view that ablative procedures should be part of the clinical armamentarium used to treat ion channel disorders, yet conclusive data are far from being available. We believe that the nuanced nature of heritable arrhythmogenic disease presents distinct challenges to mapping and radiofrequency ablation; therefore, in the present chapter we review currently available studies as well as selected cases from our experience focusing on patients with long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This edition first published 2013

AB - Management of patients with channelopathies represents a challenging field for the electrophysiologist because, given the absence of obvious structural abnormalities of the cardiac tissue, it is difficult to define paradigms for the use of mapping and ablation. Anecdotal reports and studies conducted in limited numbers of patients support the view that ablative procedures should be part of the clinical armamentarium used to treat ion channel disorders, yet conclusive data are far from being available. We believe that the nuanced nature of heritable arrhythmogenic disease presents distinct challenges to mapping and radiofrequency ablation; therefore, in the present chapter we review currently available studies as well as selected cases from our experience focusing on patients with long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This edition first published 2013

KW - Ablation

KW - Catecholaminergic

KW - Disease

KW - Genetic

KW - Inherited

KW - Long QT

KW - Mapping

KW - Ventricular arrhythmias

UR - http://www.scopus.com/inward/record.url?scp=84886682468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886682468&partnerID=8YFLogxK

U2 - 10.1002/9781118481585.ch59

DO - 10.1002/9781118481585.ch59

M3 - Chapter

AN - SCOPUS:84886682468

SN - 9780470670460

SP - 644

EP - 655

BT - Cardiac Mapping: Fourth Edition

PB - Wiley-Blackwell

ER -